Evelyn Partners Group Ltd’s Boston Scientific BSX Stock Holding History

Evelyn Partners Group Ltd’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.4M	Buy	+242,535	New	+$13.2M	0.02%	84

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Evelyn Partners Group Ltd's BSX Position: Q2 2026 in Review

Evelyn Partners Group Ltd opened a new position in Boston Scientific (BSX) in Q2 2026: 242,535 shares worth $10.4M. The stake represents 0.02% of the portfolio and ranks #84 among its holdings.

770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Evelyn Partners Group Ltd held 242,535 shares of Boston Scientific worth $10.4M as of Q2 2026.
Boston Scientific was a new Evelyn Partners Group Ltd position in Q2 2026.
Boston Scientific made up 0.02% of Evelyn Partners Group Ltd's portfolio in Q2 2026, its #84 holding.
770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.